Susan Molineaux

She co-founded Calithera in 2010. She previously co-founded Proteolix Inc., where until its 2009 acquisition by Onyx Pharmaceuticals Inc. she held numerous senior positions, including chief scientific officer and president and CEO. From 2000-2003, she was VP of biology at Rigel Pharmaceuticals Inc. Currently she is co-vice chair of Bay Bio, the life science association of Northern California.

  • 2012 Fourth Quarter

Added to: Geron Corp. - Menlo Park, CA

Geron develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases. Revenues are $2 million.